127
Participants
Start Date
July 31, 2014
Primary Completion Date
June 30, 2021
Study Completion Date
May 3, 2022
NUsurface® Meniscus Implant
The NUsurface Meniscus Implant is a Polycarbonate-Urethane (PCU)-based device reinforced with high tensile Ultra High Molecular Weight Polyethylene (UHMWPE) fibers. The product is available in different sizes, left and right, and with trials so as to allow the surgeon several size options for implantation. The NUsurface® Meniscus Implant, is designed to be conceptually analogous to the natural meniscus whose structural characteristics include a highly orientated collagen fiber network supports the large hoop stresses to produce better distribution of contact pressures within the knee joint. Restoring the distribution of joint loads post-meniscectomy is thought to reducing joint overload and to reducing pain.
NSAID's and Non-surgical Treatment Options
Non-prescription drugs, creams, vitamins, and supplements, Prescription or Non-Prescriptions NSAIDs, Non-weight bearing and/or open chain physical therapy or self-administered exercise
Intra-Articular Injections with Corticosteroids
Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).
Intra-Articular Injections with Hyaluronic Acid (HA)
Intra-articular injection of a hyaluronic acid treatment, such as SYNVISC® HA Injections.
Lenox Hill Hospital, New York
Capital Region Orthopaedics, Albany
Advanced Orthopaedics, Richmond
Duke University Medical Center, Durham
OrthoSouth, Memphis
Ohio State University Medical Center, Columbus
OrthoIndy, Indianapolis
Brigham and Woman's Hospital, Boston
New England Baptist Hospital, Roxbury Crossing
Lead Sponsor
Active Implants
INDUSTRY